Finance

Lists
Why is MARKSANS down 3.71%?
Dive Deeper
MARKSANS:NSE
Marksans Pharma Ltd
₹294.75
-3.71%
(-11.35) 1D
Nov 18, 3:21:07 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MARKSANS...
Open
₹306.20
High
₹315.55
Low
₹291.30
Mkt. cap
133.59B
Avg. vol.
1.48M
Volume
1.40M
Dividend
0.31%
Quarterly dividend
₹0.22
Ex-dividend date
Aug 20, 2026
P/E ratio
23.87
52-wk high
₹350.95
52-wk low
₹155.00
EPS
₹12.35
Shares outstanding
409.31M
No. of employees
2K
Open
₹306.20
High
₹315.55
Low
₹291.30
Mkt. cap
133.59B
Avg. vol.
1.48M
Volume
1.40M
Dividend
0.31%
Quarterly dividend
₹0.22
Ex-dividend date
Aug 20, 2026
P/E ratio
23.87
52-wk high
₹350.95
52-wk low
₹155.00
EPS
₹12.35
Shares outstanding
409.31M
No. of employees
2K
News stories
From web sources and news partners
About Marksans Pharma Ltd
CEOMark B. Saldanha
Employees1.68K
Founded1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 5, 2026
Fiscal period
Q2 2027
₹3.11 / ₹3.50
-11.14%miss
Revenue / Est. (INR)
9.40B / 8.86B
+6.15%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
7.54B
8.56B
8.41B
9.40B
Cost of goods sold
3.16B
4.51B
3.43B
3.90B
Cost of revenue
3.16B
4.51B
3.43B
3.90B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.12B
1.21B
1.14B
1.22B
Operating expense
3.02B
2.33B
3.09B
3.68B
Total operating expenses
6.18B
6.85B
6.53B
7.58B
Operating income
1.36B
1.72B
1.88B
1.82B
Other non operating income
201.44M
-441.86M
63.99M
181.50M
EBT including unusual items
1.51B
2.00B
2.07B
1.94B
EBT excluding unusual items
1.51B
1.99B
2.07B
1.94B
Income tax expense
369.34M
509.66M
471.64M
499.78M
Effective tax rate
24.52%
25.48%
22.83%
25.83%
Other operating expenses
1.65B
881.88M
1.70B
2.13B
Net income
1.13B
1.48B
1.57B
1.41B
Net profit margin
15.01%
17.30%
18.69%
15.03%
Earnings per share
2.50
3.27
3.47
3.11
Interest and investment income
-
276.78M
-
-
Interest expense
-59.35M
-63.11M
-
-68.26M
Net interest expenses
-59.35M
213.67M
-
-68.26M
Depreciation and amortization charges
243.27M
242.88M
248.64M
321.11M
EBITDA
1.50B
1.87B
2.04B
2.11B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps